Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Gross Margin: 2017-2025

Historic Gross Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to 64.73%.

  • Organogenesis Holdings' Gross Margin fell 1200.00% to 64.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 66.27%, marking a year-over-year decrease of 902.00%. This contributed to the annual value of 75.99% for FY2024, which is 57.00% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Gross Margin of 64.73% as of Q3 2025, which was up 25.58% from 51.55% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Gross Margin ranged from a high of 78.05% in Q2 2022 and a low of 51.55% during Q2 2025.
  • Moreover, its 3-year median value for Gross Margin was 75.28% (2023), whereas its average is 72.17%.
  • As far as peak fluctuations go, Organogenesis Holdings' Gross Margin spiked by 558bps in 2021, and later crashed by 2,603bps in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Gross Margin stood at 74.51% in 2021, then soared by 203bps to 76.53% in 2022, then tumbled by 440bps to 72.13% in 2023, then spiked by 335bps to 75.48% in 2024, then slumped by 1,200bps to 64.73% in 2025.
  • Its last three reported values are 64.73% in Q3 2025, 51.55% for Q2 2025, and 72.64% during Q1 2025.